Skip to main content

Global Oncology Informatics Market – Benefits to Caregivers, Payers, and Researchers

 An increasing demand from clinicians for the electronic collection of cancer-related data has led to the electronic collection of data that can efficiently facilitate personalized care for patients and catalyze real-time clinical research studies.

The importance of EHR (for electronic collection of data) has been recognized by organizations, such as the American Society of Clinical Oncology (ASCO). In 2010, ASCO released the final draft of the Certification Commission for Health Information Technology (CCHIT) criteria for the oncology EHR certification for the EHR vendors.

Under oncology informatics, the products are highlighted to cover the complete treatment process. Information is collated from different medical specialties, such as surgery, chemotherapy, pathology, and radiotherapy. There are various forms of specialist oncology information systems aimed at identifying common processing across tumor streams.

Following are the several information systems included in oncology informatics. These systems are majorly used for patient management and data recording purposes.

·         Oncology EMR: These systems are often compatible with a wide range of image types such as CT scans, PET scans, mammograms, ultrasounds, MRIs, and other scans.

·         Oncology information systems (OIS): These systems are offered by specialist suppliers in the market and are often associated with other types of oncology technology, such as linear accelerators (LINACs).

·         Oncology clinical care information systems (OCCIS): These systems offer enhanced control over all aspects of interface design, data flow, and workflow.

According to the market intelligence published by BIS Research, the global oncology informatics market is expected to grow at a significant CAGR of 7.03% during the forecast period from 2019 to 2025. With increasing incidences of cancer, the burden on clinicians to effectively manage oncology-related data to ensure enhanced patient outcomes.

. Furthermore, in recent years, organizations such as Centers for Medicare and Medicaid Services (CMS) have reduced reimbursement rates and procedure time in a clinical setting. 

This further necessitates the selection of an integrated health record system. For instance, in 2013, CMS implemented changes in payment policies, which resulted in an overall 15% reduction in rates of radiation oncology services. These changes comprised a 7% change in treatment times for intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT) procedure codes.

Further, oncology informatics has several benefits for care providers, payers, and researchers. For instance, it offers in detail aggregation of patient-related information, such as plan of treatment, its status, and patient's response to it. For caregivers, it offers storage of drug toxicity and clinical trial information at one centralized location, and for payers, it offers assistance in designing reimbursement strategies. Lastly, for researchers, it streamlines  tasks such as data retrieval, analysis, and prediction of probable outcomes.

Comments

Popular posts from this blog

Personal Care Ingredients Market Size, Share & Trends Analysis Report 2019-2029

The introduction and proliferation of bio-based ingredients in several industries, such as food and beverage, pharmaceuticals, and cosmetics, has been transforming the manufacturing landscape since 2000. Growing consumer inclination toward the adoption of bio-based products due to rising health and environmental concerns is driving the demand for bio-based ingredients in the cosmetics and personal care products. Besides, awareness among consumers regarding the harmful effects of synthetic ingredients chemicals has grown rapidly over the past years. In addition, the availability of green raw materials has also urged large cosmetic firms to develop bio-based cosmetic products. However, limited availability of raw material, due to erratic weather conditions and stringent environmental regulations, can pose substantial hurdles in the production of bio-based ingredients. Thus, leading companies have been focusing on developing new and sustainable ways of producing the ingredi...

High-End Synthetic Suede Market Latest Trend, Industry Growth, Competitive Analysis Upto 2031

High-end synthetic suede has been able to mark its presence in the fashion industry as well. Global fashion designers, with an aim to inculcate sustainability, have started to incorporate synthetic materials in their production process, to not only achieve sustainability but also to send a strong message to their customers regarding the proliferated use of vegan materials. The growth in the high-end synthetic suede market is attributable to increasing demand from the automotive industry and the need for a replacement of natural suede. Synthetic suede is made through the blends of polyester and other plastics, posing less environmental hazard just like natural suede does. Synthetic suede is typically more economical and affordable as compared to natural suede. The material is highly durable and requires low maintenance, which has made it a popular choice as a replacement of natural suede. The increase in the number of end-use industries, rise in the demand for a replacement of natural s...

Liquid Biopsy, North America, and Lung Cancer Occupying a Major Share in the Market

  Owing to the market availability of large number of liquid biopsy technologies, the liquid biopsy segment currently accounts for a dominating share in the global minimally invasive biopsy technologies market . However, the market growth in the segment can be attributed to the increasing demand for liquid biopsy and the strong product pipeline. For instance, CNI Second Opinion by Chronix Biomedical is presently under development and is expected to get launched during the forecast period 2019-2030. Owing to a widespread market presence of leading players and the huge prevalence of cancer, North America presently holds a major share in the global minimally invasive biopsy technologies market. According to the World Cancer Research Fund (WCRF), with an estimated 2 million cases in 2018, lung cancer is the most commonly occurring cancer in men and third-most commonly occurring cancer in women. Due to the widespread presence of cancer, the manufacturers including Biocept, Inc., Chron...